Mosul University
  • Register
  • Login
  • العربیة

Iraqi Journal of Pharmacy

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 14, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Peer Review Process

News

Guide to reviwers

The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City

    Mohammed Khalid J. Al-Nori Akram J. Ahmed

Iraqi Journal of Pharmacy, 2014, Volume 14, Issue 1, Pages 76-78
10.33899/iphr.2019.161197

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Diagnostic marker to detect chronic kidney disease (CKD) at early stages is important as early intervention can slow the loss of kidney functions. Serum cystatin C (sCysC) is said to be a superior marker for CKD compared to serum creatinine (sCr) and other known markers in the near past period to detect the mild GFR reduction between 60 and 90 ml/min/1.73m2.
Objective: To detect fordetecting the role of cystatin C as an early predictor for the assessment of chronic kidney disease patients.
Methods:Blood and urine samples from 185 patients suffering from various stages of CKD or subjects under the risk of CKD were taken from Ibn-Sina teaching hospital during the period from 15th of March 2012 to 10th of sept 2013. Serum Urea (sUr), serum uric acid (sUA), serum creatinine (sCr), serum cystatin C (sCysC), 24 hour excreted urine protein and 24 hour excreted urine creatinine where analyzed then compared to corrected creatinine clearance for each patient.
Results:Theresults showed that serum CysC started to change from abnormal border line level at stage 2 to clearly abnormal level at stage three of CKD comparing to other assessments which used sCr, sUr, sUA. The results also indicated that the urinary 24h excreted protein was starting to be observed at stage 3 of CKD.
Conclusions:  The present study indicated that sCysC have the potential benefit for early detection of CKD especially in those with high risk before appearance of the symptoms and before occurrence of the complications.
Keywords:
    Chronic Kidney Disease creatinine sCys C Urinary protein Urea Uric acid
  • PDF (394 K)
  • XML
(2019). The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City. Iraqi Journal of Pharmacy, 14(1), 76-78. doi: 10.33899/iphr.2019.161197
Mohammed Khalid J. Al-Nori; Akram J. Ahmed. "The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City". Iraqi Journal of Pharmacy, 14, 1, 2019, 76-78. doi: 10.33899/iphr.2019.161197
(2019). 'The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City', Iraqi Journal of Pharmacy, 14(1), pp. 76-78. doi: 10.33899/iphr.2019.161197
The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City. Iraqi Journal of Pharmacy, 2019; 14(1): 76-78. doi: 10.33899/iphr.2019.161197
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 156
  • PDF Download: 137
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus